Skip to content
  • Home
  • Company
    • About Us
    • Departments
    • Message From MD
  • Product
    • General
    • Hormones
    • Urology
    • Steroids
  • Media
    • Insights
    • Blogs
    • Gallery
  • Careers
  • Contact Us
Menu
Home / Urology / Benign Prostatic Hyperplasia Agents / PROSTAM
Benign Prostatic Hyperplasia Agents

PROSTAM

Tamsulosin is a selective antagonist at alpha-1A and alpha-1B-adrenoceptors in the prostate, prostatic capsule, prostatic urethra, and bladder neck. At least three discrete alpha1-adrenoceptor subtypes have been identified: alpha-1A, alpha-1B and alpha-1D; their distribution differs between human organs and tissue. Approximately 70% of the alpha1-receptors in human prostate are of the alpha-1A subtype. Blockage of these receptors causes relaxation of smooth muscles in the bladder neck and prostate.

QR Code

General Info

Generic Name:

Tamsulosin HCl

Therapeutic Category:

Benign Prostatic Hyperplasia Agents/Urinary Tract Antispasmodic

Pharmacological Class:

Alpha-Adrenergic Blocker

Composition:

Each capsule contains Tamsulosin HCl USP 0.4 mg

(As controlled release tablets)

Pregnancy Category:

X

Presentation:

Available in the pack size as 10 tablets X 10 blisters

Mechanism of Action:

Tamsulosin HCl which is alpha-1 adrenoreceptor blockers, selectively blocks alpha 1A -adrenergic receptors causing relaxation of prostate smooth muscle resulting in an increase in urinary flow rate and a reduction in symptoms of benign prostatic hypertrophy.

Indications:
  • Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
  • Adjunct treatment of Acute Urinary Retention (AUR): the inability to voluntarily pass urine, Bladder Outlet Obstruction (BOO): blockage at the base of the bladder.
  • Expulsion of ureteral stones up to 5mm.
Dosage:

Route of administration: Oral

Initial Dose: 0.4 mg orally once a day

Maximum Dose: 0.8 mg orally once a day

Administered on an empty stomach approximately before one-half hour following the same meal each day.

Pharmacokinetics:

Absorption: Essentially complete (>90%) following oral administration under fasting conditions.

Protein binding: Approximately 94%-99%

Metabolism: Hepatic

Route of elimination: Renal

Half-life: 5-7 hours

Adverse Effects:
  • Postural Hypotension*
  • Priapism*
  • Immunologic: Higher risk of allergic reaction in those with sulfa allergies
  • Ophthalmologic: Patients taking tamsulosin are prone to a complication known as floppy iris syndrome* during cataract surgery
Contraindications:

PROSTAM is contraindicated in the following populations and situations:

  • Intraoperative Floppy Iris Syndrome- Patients considering cataract surgery should be advised to tell their ophthalmologist
  • Severe Hypotension
Drug Interactions:
  • Enhance hypotensive effect of tamsulosin when given with antihypertensive drugs (e.g ACE inhibitors, B-Blockers, Ca channel blocker etc), adrenergic neurone blocker, alcohol, alpha blockers, Angiotensin-II receptor antagonist, antipsychotic, anxiolytic and hypnotic drugs.
Terminologies:

Postural hypotension: Also known as orthostatic hypotension is a form of low blood pressure that happens when you stand up from sitting or lying down. It can make you feel dizzy or lightheaded, and maybe even faint.

Priapism: persistent and painful erection of the penis.

Floppy iris syndrome: This syndrome is characterized by a flaccid iris which billows in response to ordinary intraocular fluid current

Related Products

MILAGE
  • Erectile dysfunction (ED)
  • Benign prostatic hyperplasia (BPH)
  • Lower urinary tract symptoms (LUTS)
  • Pulmonary arterial hypertension (PAH)

Benign Prostatic Hyperplasia Agents

MILAGE

PROSTIF
  • Benign prostatic hyperplasia (BPH)
  • Symptom relief in enlarged prostate
  • Reduces risk of acute urinary retention
  • Decreases need for BPH surgery

Benign Prostatic Hyperplasia Agents

PROSTIF

OVACT
  • Overactive bladder (urgency, frequency, incontinence)
  • Neurogenic detrusor overactivity (NDO)
  • Urge urinary incontinence
  • Frequent urination
  • Bladder control improvement

Anti-muscarinics

OVACT

UROXATE
  • Urinary frequency & incontinence
  • Dysuria & urinary urgency
  • Nocturia
  • Bladder spasms (post-catheter/procedures)
  • Cystitis & related urinary tract inflammation

Urinary Tract Spasmolytic

UROXATE

OHM Insights

View Detail

OHM INSIGHT 25th Issue

View Detail

OHM INSIGHT 24th issue

View Detail

OHM INSIGHT 23nd Issue

View Detail

OHM INSIGHTS- 22th Issue

OPL believes in developing medicines and products that are cost-effective as well are capable of providing high quality care to improve the health of the patients.

Quick Links
  • About Us
  • Contact Us
  • Products
  • Dealer Locator
  • Blogs
  • Our Team
  • Career
Product Category
  • General
  • Urology
  • Steroids
  • Hormones
Corporate Office
(+977) 4110791, 01-4110761
info@opl.com.np
Babu Ram Acharya Marg, Sinamangal, Kathmandu
Factory Office
(+977) 4110791, 01-4110761
info@opl.com.np
Tathali-09, Bhaktapur

Copyright 2026 OHM Pharmaceuticals Lab Pvt. Ltd. All Rights Reserved

Website Designed & Developed by Theme Nepal